Phase I trial of paclitaxel and gemcitabine administered every two weeks in patients with refractory solid tumors
Mace L. Rothenberg(The University of Texas Health Science Center at San Antonio), A. Sharma(The University of Texas Health Science Center at San Antonio), Geoffrey R. Weiss(The University of Texas Health Science Center at San Antonio), Miguel A. Villalona‐Calero, John R. Eckardt(The University of Texas Health Science Center at San Antonio), C. Aylesworth(Joint Base San Antonio), Maura A. Kraynak(The University of Texas Health Science Center at San Antonio), David Rinaldi(Vanderbilt University Medical Center), Gladys Rodriguez(The University of Texas Health Science Center at San Antonio), H. A. Burris, S. Gail Eckhardt, Connie Stephens, Kelly Forral, Steven J. Nicol(Eli Lilly (United States)), Daniel D. Von Hoff(The University of Texas Health Science Center at San Antonio)
Cited by 76
Abstract
Related Papers
No related papers found
Powered by citation graph analysis